# Clindamycin Phosphate In 0.9% Sodium Chloride (clindamycin phosphate) PDUFA date and FDA approval status

Canonical: https://sec-api.dev/pdufa/clindamycin

> The FDA approved Clindamycin Phosphate In 0.9% Sodium Chloride (clindamycin phosphate), sponsored by BAXTER INTERNATIONAL INC (BAX), on December 7, 2021.

Data as of November 16, 2026 (snapshot 20261116T222116Z). Every date quotes the SEC filing or FDA page it came from. Date precision: exact day.

**Free:** every drug page and the next 30 days of the FDA calendar, no account. Calendar API, alerts when a date moves, and full history: https://sec-api.dev/pricing . Free API key: https://sec-api.dev/sign-up?ref=ai-claudebot

## Key facts

| Field | Value |
| --- | --- |
| Drug | Clindamycin Phosphate In 0.9% Sodium Chloride (clindamycin phosphate) |
| Codes |  |
| Sponsor | BAXTER INTERNATIONAL INC (BAX) https://sec-api.dev/companies/bax/catalysts |
| Indications |  |
| Modality |  |
| FDA designations | priority review |

## Timeline

### April 20, 2017: FDA approval

- Status: completed, approved. Date confidence: exact.
- First seen 2026-11-12T03:48:32.313Z, last confirmed 2026-11-16T22:20:01.192Z.
- openFDA Drugs@FDA: "NDA208083 ORIG-1 (Type 5 - New Formulation or New Manufacturer): submission_status AP, submission_status_date 20170420, review_priority STANDARD; sponsor_name BAXTER HLTHCARE CORP; product CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE (CLINDAMYCIN PHOSPHATE)." https://api.fda.gov/drug/drugsfda.json?search=application_number:%22NDA208083%22

### December 7, 2021: FDA approval

- Status: completed, approved. Date confidence: exact.
- First seen 2026-11-12T03:44:55.771Z, last confirmed 2026-11-16T22:20:01.192Z.
- openFDA Drugs@FDA: "NDA215650 ORIG-1 (Type 5 - New Formulation or New Manufacturer): submission_status AP, submission_status_date 20211207, review_priority PRIORITY; sponsor_name ORGANON LLC; product XACIATO (CLINDAMYCIN PHOSPHATE)." https://api.fda.gov/drug/drugsfda.json?search=application_number:%22NDA215650%22

## Feeds and downloads

- Subscribe (iCal): https://sec-api.dev/pdufa/clindamycin.ics
- Next 30 days as CSV: https://sec-api.dev/fda-calendar.csv . JSON: https://sec-api.dev/fda-calendar.json . All events (iCal): https://sec-api.dev/fda-calendar.ics
- New or moved PDUFA dates: https://sec-api.dev/pdufa-dates/feed.xml (RSS), https://sec-api.dev/pdufa-dates/feed.json (JSON Feed)
- FDA approvals: https://sec-api.dev/fda-approvals-today/feed.xml (RSS), https://sec-api.dev/fda-approvals-today/feed.json (JSON Feed)
- License: CC BY 4.0 for the public 30-day window (https://sec-api.dev/biotech/license.txt). Full history: https://sec-api.dev/pricing

## Cite this page

sec-api.dev. "Clindamycin Phosphate In 0.9% Sodium Chloride (clindamycin phosphate) PDUFA date and FDA approval status." Biotech catalyst calendar, data as of November 16, 2026 (snapshot 20261116T222116Z). https://sec-api.dev/pdufa/clindamycin

```bibtex
@misc{secapidev_pdufa_clindamycin_20261116,
  title        = {Clindamycin Phosphate In 0.9% Sodium Chloride (clindamycin phosphate) PDUFA date and FDA approval status},
  author       = {{sec-api.dev}},
  year         = {2026},
  month        = {nov},
  howpublished = {\url{https://sec-api.dev/pdufa/clindamycin}},
  note         = {Biotech catalyst calendar, data as of 2026-11-16, snapshot 20261116T222116Z. Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source.}
}
```

```json
{"type":"dataset","id":"secapidev_pdufa_clindamycin_20261116","title":"Clindamycin Phosphate In 0.9% Sodium Chloride (clindamycin phosphate) PDUFA date and FDA approval status","publisher":"sec-api.dev","URL":"https://sec-api.dev/pdufa/clindamycin","issued":{"date-parts":[[2026,11,16]]},"version":"20261116T222116Z","license":"https://creativecommons.org/licenses/by/4.0/","note":"Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source."}
```

---
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Food and Drug Administration or the U.S. Securities and Exchange Commission. Dates are as stated by sponsors and FDA; the FDA can act before or after a target date. Not investment advice.
